홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Phosgene → HCID 67515133, 화합물

HRID 473904
인쇄

반응식

HRID 473904 반응식
[O:1]1[C:7]2[CH:8]=[CH:9][C:10]([C:12]3[CH:17]=[CH:16][C:15]([C:18]4[N:19]([C:23]([O:25][CH2:26][CH:27]([CH3:29])[CH3:28])=[O:24])[CH:20]=[CH:21][N:22]=4)=[CH:14][CH:13]=3)=[CH:11][C:6]=2[CH2:5][NH:4][CH2:3][CH2:2]1.CCN(C(C)C)C(C)C.[C:39](Cl)(Cl)=[O:40].Cl.[C:44]([CH:46]1[CH2:51][CH2:50][NH:49][CH2:48][CH2:47]1)#[N:45]>ClCCl>[C:44]([CH:46]1[CH2:51][CH2:50][N:49]([C:39]([N:4]2[CH2:5][C:6]3[CH:11]=[C:10]([C:12]4[CH:13]=[CH:14][C:15]([C:18]5[N:19]([C:23]([O:25][CH2:26][CH:27]([CH3:29])[CH3:28])=[O:24])[CH:20]=[CH:21][N:22]=5)=[CH:16][CH:17]=4)[CH:9]=[CH:8][C:7]=3[O:1][CH2:2][CH2:3]2)=[O:40])[CH2:48][CH2:47]1)#[N:45]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 6371PhosgeneHCID 81531Diisopropylethylamine2회HCID 227446374-Piperidinecarbonitrile hydrochlorideHCID 67513954HCID 67513954, 화합물

생성물 1

HCID 67515133HCID 67515133, 화합물수율 61%

시약·촉매·용매 1

HCID 6344
Dichloromethane
용매
2회

반응 조건

온도
0 °C

실험 절차

2-methylpropyl 2-[4-(2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)phenyl]-1H-imidazole-1-carboxylate (361 mg, 0.92 mmol) was taken into dichloromethane (5 mL) followed by addition of DIPEA (0.32 mL, 1.84 mmol). The solution thus obtained was added slowly by syringe over several minutes to a solution of phosgene (20 W % in toluene, 0.49 mL, 0.93 mmol) diluted in dichloromethane (5 mL) and cooled to 0° C. The resulting mixture was stirred for 5 minutes then allowed to warm to room temperature and concentrated. The residue was taken back into dichloromethane (5 mL) followed by addition of DIPEA (0.48 mL, 2.76 mmol) and 4-cyanopiperidine hydrochloride salt (156 mg, 1.06 mmol) then stirred for 12 h. The mixture was concentrated then partitioned with ethyl acetate and 10% aqueous citric acid. The organic solution was washed with brine, dried over anhydrous sodium sulfate then filtered and concentrated. The residue was purified by silica gel chromatography (100% ethyl acetate) to give 2-methylpropyl 2-(4-{4-[(4-cyanopiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}phenyl)-1H-imidazole-1-carboxylate (296 mg, 61% yield) as a crystalline solid. MS (EI) for C30H33N5O4: 529 (MH+).

후처리

  1. customThe solution thus obtained
  2. temperatureto warm to room temperature
  3. concentrationconcentrated
  4. stirringthen stirred for 12 h
  5. concentrationThe mixture was concentrated
  6. customthen partitioned with ethyl acetate and 10% aqueous citric acid
  7. washThe organic solution was washed with brine
  8. dry with materialdried over anhydrous sodium sulfate
  9. filtrationthen filtered
  10. concentrationconcentrated
  11. customThe residue was purified by silica gel chromatography (100% ethyl acetate)

출처 및 근거

ORD 기록
ord-1f6edd0b9e5248709d61f42edf95c663
출처 데이터셋
uspto-grants-2014_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08637499B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트